Veterinary Clostridium Vaccine Market Research Report – Forecast till 2027

Veterinary Clostridium Vaccine Research Report: by Product (Bovine, Ovine, Swine, Caprine, Poultry, Others), by Distribution Channels (Veterinary Hospital, Veterinary Clinic, Veterinary Research Institute, and Retail Pharmacy) - Forecast Till 2027

ID: MRFR/HC/5994-HCR | February 2021 | Region: Global | 110 pages

Veterinary Clostridium Vaccine Market Scenario:


Veterinary clostridium vaccine market size is expected to grow significantly over the forecast period. It is anticipated that the market held value of USD 461.7 million in 2017 and is projected to grow at a CAGR of 4.5% over the forecast period.


The factors such as increased awareness pertaining to zoonotic diseases, the rising incidence rate of clostridium family diseases, increased awareness relating to animal-derived products, and increase in disposable income are expected to propel the growth of the market. However, side effects associated with vaccines and high cost of the treatment hamper the market growth over the forecast period.


Segmentation


The global veterinary clostridium vaccine market has been segmented into animal type, distribution channels, and region.


Based on animal type, the market is segmented into bovine, ovine, swine, caprine, poultry, and others. The bovine segment is expected to account for the largest share segment of the market in 2017.


Based on distribution channels, the market is segmented into veterinary hospital, veterinary clinic, veterinary research institute, and retail pharmacy. The into veterinary hospital segment is expected to account for the largest share segment of the market in 2017.


The market segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The veterinary clostridium vaccine market in the Americas further segmented into North America and Latin America, with the North American market divided into the US and Canada.


The European market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.


The market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The market in the Middle East & Africa segmented into the Middle East and Africa.


Regional Market Summary


Global Veterinary Clostridium Vaccine Market Share (%), by Region, 2017


Veterinary Clostridium Vaccine Market


Source: Annual Reports and Sec filings


Geographically, the Americas is anticipated to dominate the global veterinary clostridium vaccine market owing to a well-established player, increased awareness pertaining to zoonotic diseases, rising incidence rate of clostridium family diseases, increased awareness relating animal-derived products, and increase in disposable income.


Europe is expected to hold the second largest position in the global veterinary clostridium vaccine market. The market growth in this region is attributed to increasing awareness about veterinary clostridium vaccine products.


The veterinary clostridium vaccine market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region.


The Middle East & Africa has the least share of the veterinary clostridium vaccine market.


Market Segmentation:

By Animal Type



  • Bovine

  • Ovine

  • Swine

  • Caprine

  • Poultry

  • Others


By Distribution Channel



  • Veterinary Hospital

  • Veterinary Clinic

  • Veterinary Research Institute

  • Retail Pharmacy


By Region



  • Americas

    • North America

      • US

      • Canada



    • Latin America



  • Europe

    • Western Europe

      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe



    • Eastern Europe



  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • The Middle East & Africa

    • Middle East

    • Africa




Key Players:



  • Merck & Co., Inc. (US)

  • Ceva Santé Animale (France)

  • Boehringer Ingelheim International GmbH (Germany)

  • Colorado Serum Company (US)

  • Virbac (Australia)

  • Valneva SE (France)

  • Zoetis (US)

  • Elanco Animal Health (US)

  • Bayer AG (Germany)


Intended Audience



  • Veterinary Clostridium Vaccine products Manufacturers and vendors

  • Research Organization

  • Various Research and Consulting Firms

  • Veterinary Hospital

  • Animal Health Organization and Association



Report Scope:
Report Attribute/Metric Details
  Market Size    USD 461.7 Million
  CAGR   2017-2023: 4.5%
  Base Year   2019
  Forecast Period   2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Animal Type, Distribution Channels and Region
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Merck & Co., Inc. (US), Ceva Santé Animale (France), Boehringer Ingelheim International GmbH (Germany), Colorado Serum Company (US), Virbac (Australia), Valneva SE (France), Zoetis (US), Elanco Animal Health (US), Bayer AG (Germany)
  Key Market Opportunities

  • Technological developments
  • Research & Development activities
  •   Key Market Drivers   Increased awareness about zoonotic diseases and rising prevalence of clostridium family diseases are the key factors driving the veterinary clostridium vaccine market.


    Frequently Asked Questions (FAQ) :


    Veterinary clostridium vaccine market is projected to grow at a 4.5% CAGR between 2018-2023.

    The Americas is expected to lead veterinary clostridium vaccine market.

    Veterinary hospital segment will dominate the veterinary clostridium vaccine market.

    Increased awareness about zoonotic diseases and rising prevalence of clostridium family diseases are the key factors driving the veterinary clostridium vaccine market.

    High treatment cost and certain side effects may limit the veterinary clostridium vaccine market growth.

    Table of Contents:


    Chapter 1. Report Prologue

    Chapter 2. Market Introduction

    2.1. Definition

    2.2. Scope of the Study

    2.2.1. Research Objective

    2.2.2. Assumptions

    2.2.3. Limitations

    Chapter 3. Research Methodology

    3.1. Introduction

    3.2. Primary Research

    3.3. Secondary Research

    3.4. Market Distribution Channels Estimation

    Chapter 4. Market Dynamics

    4.1. Drivers

    4.2. Restraints

    4.3. Opportunities

    4.4. Challenges

    Chapter 5. Market Factor Analysis

    5.1. Porter’s Five Forces Analysis

    5.1.1. Bargaining Power of Suppliers

    5.1.2. Bargaining Power of Buyers

    5.1.3. Threat of New Entrants

    5.1.4. Threat of Substitutes

    5.1.5. Intensity of Rivalry

    5.2. Value Chain Analysis

    5.3. Investment Feasibility Analysis

    5.4. Pricing Analysis

    Chapter 6. Global Veterinary Clostridium Vaccine Market, by Animal Type

    6.1. Introduction

    6.2. Bovine

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.3. Ovine

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.4. Swine

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.5. Caprine

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.6. Poultry

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.7. Others

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    Chapter 7. Global Veterinary Clostridium Vaccine Market, by Distribution Channels

    7.1. Introduction

    7.2. Veterinary Hospital, , Veterinary Research Institute, Retail Pharmacy

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.3. Veterinary Clinic

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.4. Veterinary Research Institute

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.5. Retail Pharmacy

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    Chapter 8. Global Veterinary Clostridium Vaccine Market, by Region

    8.1. Introduction

    8.2. Americas

    8.2.1. North America

    8.2.1.1. US

    8.2.1.2. Canada

    8.2.2. Latin America

    8.3. Europe

    8.3.1. Western Europe

    8.3.1.1. Germany

    8.3.1.2. France

    8.3.1.3. Italy

    8.3.1.4. Spain

    8.3.1.5. UK

    8.3.1.6. Rest of Western Europe

    8.3.2. Eastern Europe

    8.4. Asia-Pacific

    8.4.1. Japan

    8.4.2. China

    8.4.3. India

    8.4.4. Australia

    8.4.5. South Korea

    8.4.6. Rest of Asia-Pacific

    8.5. Middle East & Africa

    8.5.1. Middle East

    8.5.2. Africa

    Chapter 9. Company Landscape

    9.1. Introduction

    9.2. Market Share Analysis

    9.3. Key Developments & Strategies

    Chapter 10. Company Profiles

    10.1. MERCK & CO., INC.

    10.1.1. Company Overview

    10.1.2. Animal Type Overview

    10.1.3. Financials Overview

    10.1.4. Key Developments

    10.1.5. SWOT Analysis

    10.1.6. Key Strategies

    10.2. Ceva Santé Animale

    10.2.1. Company Overview

    10.2.2. Animal Type Overview

    10.2.3. Financials Overview

    10.2.4. Key Developments

    10.2.5. SWOT Analysis

    10.2.6. Key Strategies

    10.3. BOEHRINGER INGELHEIM INTERNATIONAL GMBH

    10.3.1. Company Overview

    10.3.2. Animal Type Overview

    10.3.3. Financials Overview

    10.3.4. Key Developments

    10.3.5. SWOT Analysis

    10.3.6. Key Strategies

    10.4. COLORADO SERUM COMPANY

    10.4.1. Company Overview

    10.4.2. Animal Type Overview

    10.4.3. Financials Overview

    10.4.4. Key Developments

    10.4.5. SWOT Analysis

    10.4.6. Key Strategies

    10.5. Virbac

    10.5.1. Company Overview

    10.5.2. Animal Type Overview

    10.5.3. Financials Overview

    10.5.4. Key Developments

    10.5.5. SWOT Analysis

    10.5.6. Key Strategies

    10.6. Valneva SE

    10.6.1. Company Overview

    10.6.2. Animal Type Overview

    10.6.3. Financials Overview

    10.6.4. Key Developments

    10.6.5. SWOT Analysis

    10.6.6. Key Strategies

    10.7. Zoetis

    10.7.1. Company Overview

    10.7.2. Animal Type Overview

    10.7.3. Financials Overview

    10.7.4. Key Developments

    10.7.5. SWOT Analysis

    10.7.6. Key Strategies

    10.8. Elanco Animal Health

    10.8.1. Company Overview

    10.8.2. Animal Type Overview

    10.8.3. Financials Overview

    10.8.4. Key Developments

    10.8.5. SWOT Analysis

    10.8.6. Key Strategies

    10.9. Bayer AG

    10.9.1. Company Overview

    10.9.2. Animal Type Overview

    10.9.3. Financials Overview

    10.9.4. Key Developments

    10.9.5. SWOT Analysis

    10.9.6. Key Strategies

    10.10. Others

    Chapter 11. MRFR Conclusion

    11.1. Key Findings

    11.1.1. From CEO’s View point

    11.1.2. Unmet Needs of the Market

    11.2. Key Companies to Watch

    11.3. Predictions for the Veterinary Clostridium Vaccine Industry

    Chapter 12. Appendix

    LIST OF TABLES

    Table 1. Global Veterinary Clostridium Vaccine Market Synopsis, 2020-2027

    Table 2. Global Veterinary Clostridium Vaccine Market Estimates and Forecast, 2020-2027 (USD Million)

    Table 3. Global Veterinary Clostridium Vaccine Market, by Region, 2020-2027 (USD Million)

    Table 4. Global Veterinary Clostridium Vaccine Market, by Animal Type, 2020-2027 (USD Million)

    Table 5. Global Veterinary Clostridium Vaccine Market, by Distribution Channels, 2020-2027 (USD Million)

    Table 6. North America: Veterinary Clostridium Vaccine Market, by Animal Type, 2020-2027 (USD Million)

    Table 7. North America: Veterinary Clostridium Vaccine Market, by Distribution Channels, 2020-2027 (USD Million)

    Table 8. US: Veterinary Clostridium Vaccine Market, by Animal Type, 2020-2027 (USD Million)

    Table 9. US: Veterinary Clostridium Vaccine Market, by Distribution Channels, 2020-2027 (USD Million)

    Table 10. Canada: Veterinary Clostridium Vaccine Market, by Animal Type, 2020-2027 (USD Million)

    Table 11. Canada: Veterinary Clostridium Vaccine Market, by Distribution Channels, 2020-2027 (USD Million)

    Table 12. Latin America: Veterinary Clostridium Vaccine Market, by Animal Type, 2020-2027 (USD Million)

    Table 13. Latin America: Veterinary Clostridium Vaccine Market, by Distribution Channels, 2020-2027 (USD Million)

    Table 14. Europe: Veterinary Clostridium Vaccine Market, by Animal Type, 2020-2027 (USD Million)

    Table 15. Europe: Veterinary Clostridium Vaccine Market, by Distribution Channels, 2020-2027 (USD Million)

    Table 16. Western Europe: Veterinary Clostridium Vaccine Market, by Animal Type, 2020-2027 (USD Million)

    Table 17. Western Europe: Veterinary Clostridium Vaccine Market, by Distribution Channels, 2020-2027 (USD Million)

    Table 18. Eastern Europe: Veterinary Clostridium Vaccine Market, by Animal Type, 2020-2027 (USD Million)

    Table 19. Eastern Europe: Veterinary Clostridium Vaccine Market, by Distribution Channels, 2020-2027 (USD Million)

    Table 20. Asia-Pacific: Veterinary Clostridium Vaccine Market, by Animal Type, 2020-2027 (USD Million)

    Table 21. Asia-Pacific: Veterinary Clostridium Vaccine Market, by Distribution Channels, 2020-2027 (USD Million)

    Table 22. Middle East & Africa: Veterinary Clostridium Vaccine Market, by Animal Type, 2020-2027 (USD Million)

    Table 23. Middle East & Africa: Veterinary Clostridium Vaccine Market, by Distribution Channels, 2020-2027 (USD Million)

    LIST OF FIGURES

    Figure 1. Research Process

    Figure 2. Segmentation for Global Veterinary Clostridium Vaccine Market

    Figure 3. Market Dynamics for Global Veterinary Clostridium Vaccine Market

    Figure 4. Global Veterinary Clostridium Vaccine Market Share, by Animal Type, 2020

    Figure 5. Global Veterinary Clostridium Vaccine Market Share, by Distribution Channels, 2020

    Figure 6. Global Veterinary Clostridium Vaccine Market Share, by Region, 2020

    Figure 7. North America: Veterinary Clostridium Vaccine Market Share, by Country, 2020

    Figure 8. Europe: Veterinary Clostridium Vaccine Market Share, by Country, 2020

    Figure 9. Asia-Pacific: Veterinary Clostridium Vaccine Market Share, by Country, 2020

    Figure 10. Middle East & Africa: Veterinary Clostridium Vaccine Market Share, by Country, 2020

    Figure 11. Global Veterinary Clostridium Vaccine Market: Company Share Analysis, 2020 (%)

    Figure 12. MERCK & CO., INC.: Key Financials

    Figure 13. MERCK & CO., INC.: Segmental Revenue

    Figure 14. MERCK & CO., INC.: Geographical Revenue

    Figure 15. Ceva Santé Animale: Key Financials

    Figure 16. Ceva Santé Animale: Segmental Revenue

    Figure 17. Ceva Santé Animale: Geographical Revenue

    Figure 18. BOEHRINGER INGELHEIM INTERNATIONAL GMBH: Key Financials

    Figure 19. BOEHRINGER INGELHEIM INTERNATIONAL GMBH: Segmental Revenue

    Figure 20. BOEHRINGER INGELHEIM INTERNATIONAL GMBH: Geographical Revenue

    Figure 21. COLORADO SERUM COMPANY: Key Financials

    Figure 22. COLORADO SERUM COMPANY: Segmental Revenue

    Figure 23. COLORADO SERUM COMPANY: Geographical Revenue

    Figure 24. Virbac: Key Financials

    Figure 25. Virbac: Segmental Revenue

    Figure 26. Virbac: Geographical Revenue

    Figure 27. Valneva SE: Key Financials

    Figure 28. Valneva SE: Segmental Revenue

    Figure 29. Valneva SE: Geographical Revenue

    Figure 30. Zoetis: Key Financials

    Figure 31. Zoetis: Segmental Revenue

    Figure 32. Zoetis: Geographical Revenue

    Figure 33. Elanco Animal Health: Key Financials

    Figure 34. Elanco Animal Health: Segmental Revenue

    Figure 35. Elanco Animal Health: Geographical Revenue

    Figure 36. Bayer AG: Key Financials

    Figure 37. Bayer AG: Segmental Revenue

    Figure 38. Bayer AG: Geographical Revenue



    This table of content is tentative and subject to change as the research progresses.

    Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.